Glaukos (GKOS) Cash from Operations (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -283.34% |
| Dec 31, 2025 | 167.71% |
| Sep 30, 2025 | -244.58% |
| Jun 30, 2025 | 137.68% |
| Mar 31, 2025 | -3,753.06% |
| Dec 31, 2024 | 105.29% |
| Sep 30, 2024 | 47.81% |
| Jun 30, 2024 | 45.77% |
| Mar 31, 2024 | -217.58% |
| Dec 31, 2023 | -30.57% |
| Sep 30, 2023 | -0.09% |
| Jun 30, 2023 | 73.47% |
| Mar 31, 2023 | -643.81% |
| Dec 31, 2022 | 84.40% |
| Sep 30, 2022 | -117.23% |
| Jun 30, 2022 | -224.88% |
| Mar 31, 2022 | 310.15% |
| Dec 31, 2021 | -126.14% |
| Sep 30, 2021 | 140.70% |
| Jun 30, 2021 | 76.90% |
| Mar 31, 2021 | -60.60% |
| Dec 31, 2020 | 210.80% |
| Sep 30, 2020 | 12.39% |
| Jun 30, 2020 | 16.61% |
| Mar 31, 2020 | -212.55% |
| Dec 31, 2019 | -40.26% |
| Sep 30, 2019 | -145.26% |
| Jun 30, 2019 | 3,074.04% |
| Mar 31, 2019 | -98.79% |
| Dec 31, 2018 | 292.66% |
| Sep 30, 2018 | 14.01% |
| Jun 30, 2018 | 159.30% |
| Mar 31, 2018 | -151.77% |
| Dec 31, 2017 | 78.26% |
| Sep 30, 2017 | 62.13% |
| Jun 30, 2017 | 85.38% |
| Mar 31, 2017 | -29.04% |
| Dec 31, 2016 | -16.57% |
| Sep 30, 2016 | -34.94% |
| Jun 30, 2016 | 744.50% |
| Mar 31, 2016 | -64.39% |
| Dec 31, 2015 | -2.33% |
| Sep 30, 2015 | 33.53% |
| Jun 30, 2015 | 18.88% |
| Mar 31, 2015 | 30.67% |
| Dec 31, 2014 | -223.21% |
| Sep 30, 2014 | -129.35% |